Explore

Streams

Products

About Index

Index

By TNW

GlaxoSmithKline

1728

GlaxoSmithKline

We’re a science-led global healthcare company on a mission to help people to do more, feel better, live longer. Twitter code of conduct on our site

Founded

1830

Follow us

Also headquartered in London

Companies in the same industry

Alexa global traffic share

Twitter followers

Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing

Built with ❤︎ by Datalicious ©2019
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 8

Apps 55

Add info

Team Size

10000+

Employees

Location

London , United Kingdom

Headquarters

,

COI Pharmaceuticals acquires Calporta by Merck

After Investing, GSK to Buy Out Celiac Drug Developer Sitari Pharma

GlaxoSmithKline steps into the myeloma game at European hematology conference

AI drug development partnership between GlaxoSmithKline, Exscientia yields first drug candidate

GlaxoSmithKline to look for early-stage assets: CEO

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion: Reuters

GlaxoSmithKline to buy cancer-focused Tesaro for $5.1 billion

Unilever wins race for GSK's consumer healthcare biz in India

GSK Awards Global Panadol Creative Business to Bespoke WPP Team

Consolidation is the way forward for healthcare: GSK Velu at VCCircle summit

GSK Sends $1.5 Billion Media Account to Publicis

Nestle, Unilever, Coke bid for GSK's India Horlicks business

GSK invests $300M into 23andme in return for four-year development partnership - SiliconANGLE

Funding

,

GSK's new R&D head bets on genetics with $300 million 23andMe deal

Earnings Health Science

All 6 Major Agency Networks Invited to Pitch for GSK's Global Media Account

Advertising

GSK Tries to Fix Pharma on a Budget

Health Strategy

As Novartis Buys In to Gene Therapy, GSK Bows Out with Orchard Deal

Health Science Stock markets

,

GSK buys out Novartis in $13 billion consumer healthcare shake-up

Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi

Health

GSK Hands Nerve Drug Back to Ionis as RNA Battle Heats Up

Health Science